SUPER HERBS 350 mg — Class I drug recall D-0909-2016
Terminated recall by Super Herbs, reported 2016-06-01. Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active me
| Recall number | D-0909-2016 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Super Herbs, Miami, FL, United States |
| Recall initiated | 2015-11-23 |
| Classified | 2016-05-26 |
| Reported by FDA | 2016-06-01 |
| Terminated | 2024-10-01 |
| Quantity | 9 bottles |
| Reason classes | undeclared allergen, unapproved product |
Product
SUPER HERBS 350 mg, 30 capsules per bottle.
Reason for recall
Marketed without an approved NDA/ANDA - presence of undeclared sibutramine, desmethylsibutramine (an active metabolite of sibutramine) and/or phenolphthalein.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0909-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.